Pediatrics
Audio Summaries

Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial 

The authors aimed to determine whether inhibition of the renin-angiotensin-aldosterone system (RAASi) is associated with a reduction in hemocompatibility-related adverse events (HRAE) in patients with durable left ventricular assist devices (LVAD). Their analysis of 1,855 patients from the MOMENTUM-3 trial revealed that RAASi therapy significantly lowered the rates of composite HRAEs, particularly non-surgical bleeding, suggesting that pharmacological modulation of neurohormonal pathways could enhance long-term outcomes in LVAD therapy.

Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial

The DECISION trial aimed to determine the safety of withdrawing digoxin in patients with heart failure who were optimized on contemporary medical therapy. The study found that discontinuation of digoxin led to a significant increase in adverse cardiovascular events and clinical deterioration compared to placebo, suggesting that caution is warranted when stopping digoxin in this patient population.

Randomized Sham Controlled Trial of Translumbosacral Neuromodulation Therapy for Fecal Incontinence

The authors aimed to evaluate the efficacy and safety of translumbosacral neuromodulation therapy (TNT) for treating fecal incontinence (FI) in a randomized sham-controlled trial. Results indicated that both 2400 and 3600 magnetic pulse treatments significantly reduced weekly FI episodes and improved bowel symptoms compared to sham treatment, with no serious adverse events reported, demonstrating that TNT is a promising non-invasive option for FI management.

Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies

The authors investigate how Mezigdomide, an immunomodulatory drug, can reduce T cell dysfunction in multiple myeloma (MM) patients and enhance the efficacy of anti-myeloma therapies. They find that Mezigdomide decreases populations of dysfunctional T cells by targeting the transcription factor Ikaros, which regulates exhaustion markers like TIGIT, ultimately improving T cell function and survival outcomes in CAR-T therapy. This study highlights the potential of Mezigdomide to improve treatment responses in MM by mitigating T cell exhaustion.

Medial Meniscus Posterior Root Repair in Knees With ≥5° of Varus Alignment Is Associated With Greater Osteoarthritis Progression Compared With <5° Varus Alignment

The authors aimed to assess the impact of mechanical alignment on the progression of osteoarthritis (OA) following isolated medial meniscus posterior root (MMPR) repair. Their findings indicate that knees with varus alignment (≥5°) experienced significantly greater OA progression, higher rates of repair failure, and increased conversion to total knee arthroplasty compared to those with normal alignment (<5°), despite similar patient-reported outcomes. The study highlights the importance of baseline alignment and repair integrity as critical factors influencing postoperative joint survival.

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)

The authors aimed to determine whether ivermectin improves outcomes for critically and noncritically ill hospitalized patients with COVID-19. The study found that ivermectin did not significantly enhance organ support-free days or hospital survival compared to the control group in both critically and noncritically ill patients, suggesting that it is unlikely to provide clinical benefit in this population.

Surgical Management of SLAP Lesions in Baseball Throwers: Posterosuperior and Posterior Labral Debridement With or Without Anterosuperior Repair Yields High Return to Play Rates

The authors aimed to evaluate the clinical outcomes and return to play (RTPL) rates of a surgical strategy for managing SLAP lesions in competitive baseball throwers, specifically comparing posterosuperior and posterior labral debridement with or without anterosuperior repair. Their findings indicated a high overall RTPL rate of 79%, with no significant differences between the two surgical approaches, suggesting that avoiding rigid fixation of the posterosuperior labrum may enhance recovery outcomes for these athletes.

"We Talk About Everything": Experiences with Digital Health Communication in Palliative Care

The authors aimed to assess patient and caregiver experiences with digital communication tools in outpatient palliative care. Through qualitative interviews, they identified key themes, including the distinct roles of video and in-person visits, the potential for building trust via video, and the high engagement with patient portals despite usability challenges. The findings suggest a need for a flexible approach to care and advocate for improved digital tool usability and permanent telehealth extensions.

T cell plasticity in systemic lupus erythematosus revealed by large-scale T cell receptor repertoire and transcriptome studies

The authors aimed to characterize the plasticity of CD4⁺ T cells in systemic lupus erythematosus (SLE) by analyzing T cell receptor (TCR) repertoire and transcriptomic data from a large cohort of SLE patients. They discovered a significant association between effector regulatory T cells and Th1 cells, revealing a Treg-associated Th1 state that correlates with disease activity in SLE. This study highlights the complex interplay between T cell subtypes in the context of autoimmune disease.

Purine Metabolism Regulates the Severity of APOL1 Nephropathy

This study investigates how purine metabolism influences the severity of nephropathy associated with high-risk APOL1 genotypes in African Americans. The authors found that impaired purine biosynthesis and subsequent ATP depletion are significant factors in disease progression, and that supplementation with the purine precursor AICAr can alleviate cellular injury and reduce albuminuria in models of APOL1 nephropathy. These findings suggest that targeting purine metabolism may offer therapeutic potential for managing APOL1-related kidney disease.